Page last updated: 2024-09-03

1-propargyl-5-chloropyrimidin-2-one and 2-(2-thenyl)sulfonyl-5-bromopyrimidine

1-propargyl-5-chloropyrimidin-2-one has been researched along with 2-(2-thenyl)sulfonyl-5-bromopyrimidine in 1 studies

*2-(2-thenyl)sulfonyl-5-bromopyrimidine: induces cell cycle specific inhibition in metaphase; structure given in first source [MeSH]

*2-(2-thenyl)sulfonyl-5-bromopyrimidine: induces cell cycle specific inhibition in metaphase; structure given in first source [MeSH]

Compound Research Comparison

Studies
(1-propargyl-5-chloropyrimidin-2-one)
Trials
(1-propargyl-5-chloropyrimidin-2-one)
Recent Studies (post-2010)
(1-propargyl-5-chloropyrimidin-2-one)
Studies
(2-(2-thenyl)sulfonyl-5-bromopyrimidine)
Trials
(2-(2-thenyl)sulfonyl-5-bromopyrimidine)
Recent Studies (post-2010) (2-(2-thenyl)sulfonyl-5-bromopyrimidine)
800500

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dornish, JM; Nygaard, ME; Oftebro, R; Pettersen, EO1

Other Studies

1 other study(ies) available for 1-propargyl-5-chloropyrimidin-2-one and 2-(2-thenyl)sulfonyl-5-bromopyrimidine

ArticleYear
Sulfhydryl-related reduction of the mitotic inhibition and cell inactivation induced by pyrimidine analogs.
    Anti-cancer drug design, 1988, Volume: 3, Issue:1

    Topics: Cell Cycle; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Cysteine; Cystine; Glutathione; Humans; Mitosis; Mitotic Index; Pyrimidines; Pyrimidinones; Sulfhydryl Compounds

1988